Information Provided By:
Fly News Breaks for February 3, 2016
BLUE
Feb 3, 2016 | 08:02 EDT
Leerink analyst Michael Schmidt started bluebird bio with an Outperform rating and $67 price target. Expectations for bluebird's pipeline have come down and the company is well positioned to overcome "remaining technical hurdles," Schmidt tells investors in a research note.